This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Valeri Runtz: Innovator in Cephalosporin Derivatives
Introduction
Valeri Runtz is a notable inventor based in Rixheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin derivatives. His work has implications for the treatment of various bacterial infections.
Latest Patents
Runtz holds a patent for cephalosporin derivatives, which relates to compounds of a specific formula. The invention includes compounds where R¹ is selected from various hydroxyphenyl groups, as well as readily hydrolyzable esters, pharmaceutically acceptable salts, and hydrates of these compounds. This innovation is crucial for advancing antibiotic therapies.
Career Highlights
Valeri Runtz is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has focused on developing new compounds that can enhance the efficacy of existing treatments. His patent portfolio reflects his commitment to innovation in medicine.
Collaborations
Runtz has collaborated with esteemed colleagues such as Paul Hebeisen and Ingrid Heinze-Krauss. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Valeri Runtz is a prominent figure in the field of pharmaceuticals, with a focus on cephalosporin derivatives. His contributions through patents and collaborations highlight his dedication to advancing medical science. His work continues to impact the development of effective treatments for bacterial infections.